Bulletin
Investor Alert

New York Markets Open in:

Company Close Updates

May 26, 2022, 4:31 p.m. EDT

Moderna Inc. stock rises Thursday, outperforms market

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) rose 3.78% to $135.80 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) rising 2.68% to 11,740.65 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.61% to 32,637.19. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $361.69 short of its 52-week high ($497.49), which the company achieved on August 10th.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. (NYS:ABBV) fell 0.91% to $150.57, Amgen Inc. (NAS:AMGN) rose 0.02% to $253.05, and AstraZeneca PLC ADR (NAS:AZN) fell 0.16% to $66.70. Trading volume (5.1 M) remained 1.5 million below its 50-day average volume of 6.6 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.